ArticleTransplantation and cellular therapy2023

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.

Jonathan A Webster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.